FDA Inspection
Bausch & Lomb IncorporatedBausch & Lomb Incorporated – FDA Inspection, Aug 25, 2023
Record Details
This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on August 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b911fb20-0187-4ef8-81b2-29e502aa8a51
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1218198
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bausch & Lomb Incorporated
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Florida District Office | |
| January 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| February 25, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch & Lomb Incorporated
- FDA Inspection 1304548 - 2026-03-20
- FDA Inspection 1082137 - 2019-01-30
- FDA Inspection 1061913 - 2018-08-10
- FDA Inspection 1015001 - 2017-05-26
- FDA Inspection 967714 - 2016-02-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.